Minimally Invasive Versus Sternotomy for Mitral Surgery in the Elderly: A Systematic Review and Meta-Analysis

Ali Hage1,2, Fadi Hage1,2, Hussein Al-Amodi1

  • 1622170384 Western University, London, ON, Canada.

Abstract

Insights

Minimally invasive mitral valve surgery (MIMVS) in elderly patients shows fewer complications and shorter hospital stays compared to conventional sternotomy (CS). However, MIMVS involves longer cross-clamp and bypass times, with similar mortality rates.

Area of Science:

  • Cardiovascular Surgery
  • Thoracic Surgery
  • Minimally Invasive Procedures

Background:

  • The safety and efficacy of minimally invasive mitral valve surgery (MIMVS) in elderly patients (≥65 years) remain subjects of ongoing debate.
  • Conventional sternotomy (CS) is the traditional approach for mitral valve surgery.

Purpose of the Study:

  • To systematically review and meta-analyze existing studies comparing MIMVS with CS in elderly patients undergoing mitral valve surgery.
  • To evaluate postoperative outcomes, including complications, length of stay, and procedural times.

Main Methods:

  • A comprehensive literature search was conducted across major databases (PubMed, EMBASE, Web of Science) and clinical trial registries.
  • Included were randomized controlled trials and observational studies comparing MIMVS and CS in patients aged 65 and older.
  • A random-effects meta-analysis was performed to synthesize data on various outcomes.

Main Results:

  • MIMVS was associated with significantly lower odds of acute renal failure, prolonged intubation, and reduced need for blood product transfusion.
  • Patients undergoing MIMVS experienced shorter intensive care unit (ICU) and hospital lengths of stay (LOS).
  • No significant differences were observed in mortality, stroke, respiratory infection, reoperation for bleeding, or postoperative atrial fibrillation rates. MIMVS did involve longer cross-clamp and cardiopulmonary bypass times.

Conclusions:

  • Minimally invasive mitral valve surgery (MIMVS) offers significant advantages in reducing postoperative complications and hospital LOS for elderly patients compared to conventional sternotomy (CS).
  • Despite longer procedural times (cross-clamp and bypass), MIMVS demonstrates a favorable safety profile in this demographic.
  • These findings support the consideration of MIMVS as a viable option for elderly patients requiring mitral valve surgery.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
93
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
110
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
141
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
74
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
125
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
114